ABBV
AbbVie Inc.
Healthcare · NYSE · Market cap $447.7bn
$285.42
as of 16 Oct 2026, 2% below its 52-week high
Last paid
Quarterly
$1.73
+5.5% on the same payment last year.
- Ex-dividend date
- 15 Jul 2026
- Pay date
- 14 Aug 2026
Next dividend
EstimatedQuarterly
about $1.82
Our estimate from the payment pattern. It changes once the company declares.
- Ex-dividend date
- 16 Jan 2027
- Pay date
- 17 Feb 2027
Div Impact 0.64%
The payment as a share of today’s price. Shares tend to drop by roughly this much on the ex-dividend date, because buyers from then on no longer get the payment.
- 1-year change
- +5.8%FY2024 to FY2025
- 3-year growth, per year
- +5.2%FY2022 to FY2025
- 5-year growth, per year
- +6.8%FY2020 to FY2025
- 10-year growth, per year
- +12.5%FY2015 to FY2025
- Years without a cut
- 12No cut since FY2014
- Regular dividends
- Year so far
ABBV dividends by fiscal year
Totals and changes leave out special dividends.
| Year | Q1 | Q2 | Q3 | Q4 | Special | Total | Change |
|---|---|---|---|---|---|---|---|
| FY2026 (so far) | $1.73 | $1.73 | $1.73 | $1.73 | $6.92 | n/a | |
| FY2025 | $1.64 | $1.64 | $1.64 | $1.64 | $6.56 | +5.8% | |
| FY2024 | $1.55 | $1.55 | $1.55 | $1.55 | $6.20 | +4.7% | |
| FY2023 | $1.48 | $1.48 | $1.48 | $1.48 | $5.92 | +5.0% | |
| FY2022 | $1.41 | $1.41 | $1.41 | $1.41 | $5.64 | +8.5% | |
| FY2021 | $1.30 | $1.30 | $1.30 | $1.30 | $5.20 | +10.2% | |
| FY2020 | $1.18 | $1.18 | $1.18 | $1.18 | $4.72 | +10.3% | |
| FY2019 | $1.07 | $1.07 | $1.07 | $1.07 | $4.28 | +19.2% | |
| FY2018 | $0.71 | $0.96 | $0.96 | $0.96 | $3.59 | +40.2% | |
| FY2017 | $0.64 | $0.64 | $0.64 | $0.64 | $2.56 | +12.3% | |
| FY2016 | $0.57 | $0.57 | $0.57 | $0.57 | $2.28 | +12.9% | |
| FY2015 | $0.49 | $0.51 | $0.51 | $0.51 | $2.02 | +21.7% | |
| FY2014 | $0.40 | $0.42 | $0.42 | $0.42 | $1.66 | +3.7% | |
| FY2013 | $0.40 | $0.40 | $0.40 | $0.40 | $1.60 | n/a |
Amounts are per share as paid, adjusted only for later changes in the number of shares. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.